|
-> ESC 2008
9/8/2008 |
Triton TIMI 38: STEMI Subset
Montalescot |
9/8/2008 |
The SYNTAX Study
Patrick W. Serruys, MD, PhD and Friedrich W. Mohr, MD, PhD |
9/8/2008 |
HORIZONS AMI Trial
Mehran |
9/8/2008 |
Decrease III
Poldermans |
9/8/2008 |
Coronary Artery Revascularization Diabetes Trial
CARDIA |
9/4/2008 |
Take Home Messages for Practitioners: Risk Stratification and Coronary Artery Disease
Sigmund Silber, MD, PhD |
9/4/2008 |
3T/2R
M. Valgimigli, MD, PhD |
9/3/2008 |
Simvastatin Ezetimibe in Aortic Stenosis
Terje R. Pedersen |
9/3/2008 |
Results from the APPRAISE-1 Dose Guiding Trial
John H. Alexander, MD, MHSc and Lars Wallentin, MD, PhD |
9/3/2008 |
F.I.R.E. Study
Dan Atar, MD |
9/2/2008 |
Biolimus-Eluting Stent with Biodegradable Polymer Versus Sirolimus-eluting Stent with Durable Polymer: A Randomised, Non-Inferiority Trial
Stephan Windecker, et al |
9/2/2008 |
Differences in Restenosis Rate with Different Drug-eluting Stents in Diabetic and Non-diabetic Patients
B. Lagerqvist, J. Carlsson, O. Frobert, J. Lindback, U. Stenestrand and S. James |
9/2/2008 |
The Potential Clinical Utility of Intravascular Ultrasound Guidance in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents
Ron Waksman, MD; Probal Roy, MD; et al |
|
|